Efficacy of ketamine for major depressive episodes at 2, 4, and 6-weeks post-treatment: A meta-analysis.
Ashley A ConleyAmber E Q NorwoodThomas C HatvanyJames D GriffithKathryn E BarberPublished in: Psychopharmacology (2021)
The results from the present meta-analysis indicate that ketamine can be an effective pharmacologic intervention for major depressive episodes, with treatment effects lasting up to 6 weeks post-ketamine administration, which has many positive implications for treatment.